HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
16 hedge funds and large institutions have $420K invested in Hepion Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$360K | |
| 2 | +$43.4K | |
| 3 | +$7K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$6.7K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$43 |
Top Sellers
| 1 | -$23.6K | |
| 2 | -$21.2K | |
| 3 | -$12.2K | |
| 4 |
Renaissance Technologies
New York
|
-$8.16K |
| 5 |
State Street
Boston,
Massachusetts
|
-$7.37K |
